{
  "id": "New-v26-1772083398391-6640",
  "stem": "Match the following hormones with their primary effect on blood glucose levels:",
  "type": "dragAndDropCloze",
  "scoring": {
    "method": "partialCredit",
    "maxPoints": 3
  },
  "stimuli": [
    {
      "id": "insulin",
      "content": "Insulin"
    },
    {
      "id": "glucagon",
      "content": "Glucagon"
    },
    {
      "id": "cortisol",
      "content": "Cortisol"
    }
  ],
  "pedagogy": {
    "cjmmStep": "analyzeCues",
    "topicTags": [
      "General"
    ],
    "bloomLevel": "apply",
    "difficulty": 3,
    "nclexCategory": "Physiological Adaptation"
  },
  "rationale": {
    "correct": "Insulin lowers blood glucose by facilitating glucose uptake into cells. Glucagon raises blood glucose by stimulating glycogenolysis and gluconeogenesis. Cortisol raises blood glucose by promoting gluconeogenesis and inhibiting insulin action.",
    "mnemonic": {
      "glucoseRegulation": "Think 'I-G-C': Insulin (lowers), Glucagon (raises), Cortisol (raises)."
    },
    "incorrect": "Incorrect matching suggests a misunderstanding of the primary regulatory effects of these hormones on glucose metabolism. Consider the source (pancreas vs adrenal cortex) and action (anabolic vs catabolic) of each hormone.",
    "questionTrap": {
      "reason": "Epinephrine does raise blood glucose, but the question asked for the *primary* effect. Epinephrine has a more immediate and acute effect, but cortisol and glucagon have more prolonged/significant effects in this context.",
      "distractor": "Epinephrine"
    },
    "clinicalPearls": [
      "Understanding the counter-regulatory hormones (glucagon, cortisol, epinephrine, growth hormone) is critical in managing hyperglycemia and hypoglycemia.",
      "Insulin resistance is a key feature of type 2 diabetes, requiring higher doses of insulin or other agents to achieve glycemic control."
    ]
  },
  "itemContext": {
    "sbar": "Patient is a 52-year-old female with a history of Type 2 Diabetes presenting with complaints of fatigue and increased thirst for the past month. Blood glucose levels have been poorly controlled despite oral hypoglycemic agents. Reviewing endocrine panel.",
    "tabs": [
      {
        "id": "sbar",
        "title": "Sbar",
        "content": "<p>No significant findings at this time.</p>"
      },
      {
        "id": "vitals",
        "title": "Vitals",
        "content": "<p>No significant findings at this time.</p>"
      },
      {
        "id": "labs",
        "title": "Labs",
        "content": "<p>No significant findings at this time.</p>"
      },
      {
        "id": "physicalExam",
        "title": "PhysicalExam",
        "content": "<p>No significant findings at this time.</p>"
      },
      {
        "id": "radiology",
        "title": "Radiology",
        "content": "<p>No significant findings at this time.</p>"
      },
      {
        "id": "carePlan",
        "title": "CarePlan",
        "content": "<p>No significant findings at this time.</p>"
      },
      {
        "id": "mar",
        "title": "Mar",
        "content": "<p>No significant findings at this time.</p>"
      }
    ],
    "patient": {
      "age": 52,
      "gender": "Female",
      "allergies": "NKDA",
      "chiefComplaint": "Fatigue and increased thirst",
      "medicalHistory": "Type 2 Diabetes, Hypertension, Hyperlipidemia"
    }
  },
  "sentinelStatus": "healed_v2026_v20_qi_final",
  "correctResponse": {
    "insulin": "Lowers Blood Glucose",
    "cortisol": "Raises Blood Glucose",
    "glucagon": "Raises Blood Glucose"
  },
  "interactionType": "dragAndDropCloze",
  "possibleResponses": [
    "Raises Blood Glucose",
    "Lowers Blood Glucose",
    "No Effect on Blood Glucose"
  ]
}